The role of toxicology assessment in transfusion medicine

Transfusion

Volumn 43, Issue 10, 2003, Pages 1481-1492

  Ciaravino, Vic ^b   McCullough, Tim ^a   Cimino, George ^b  

^a CERUS CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOTOSALEN; NONOXINOL 9; PSORALEN DERIVATIVE; UNCLASSIFIED DRUG;

ACUTE TOXICITY; BASE PAIRING; BLOOD TRANSFUSION; CARCINOGENICITY; CARDIOTOXICITY; CHRONIC TOXICITY; DEVICE; DNA ADDUCT; DNA CROSS LINKING; GENOTOXICITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILLUMINATION; INFECTION RISK; LETHAL DOSE; NONHUMAN; PHOTOACTIVATION; PHOTOTOXICITY; PLASMA TRANSFUSION; REPRODUCTIVE TOXICITY; REVIEW; RISK ASSESSMENT; STANDARD; TOXICITY TESTING; TOXICOKINETICS; TOXICOLOGICAL PARAMETERS; ULTRAVIOLET RADIATION; VIRUS INACTIVATION; VIRUS TRANSMISSION; ANIMAL; CONTACT DERMATITIS; HUMAN; METHODOLOGY; PHARMACOKINETICS; TOXICOLOGY;

ANIMALS; BLOOD TRANSFUSION; DERMATITIS, PHOTOTOXIC; HUMANS; PHARMACOKINETICS; RESEARCH DESIGN; RISK ASSESSMENT; TOXICOLOGY;

EID: 0142103771     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00544.x     Document Type: Review

References (27)

1. Barbara J. The rationale for pathogen inactivation treatment of platelet components-introduction. Semin Hematol 2001;38(4 Suppl 11):1-3.
2. Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. Sixth ed. New York: McGraw-Hill; 2001:11.
3. Science and judgement. Washington: National Research Council, National Academy of Sciences; 1994.
4. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861-9.
5. Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. Sixth ed. New York: McGraw-Hill; New York 2001:1149.
6. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (Internet). Geneva: ICH; 1998. Available from: http://www.ich.org.
7. ICH topics and guidelines, safety topics M3: timing of preclinical studies in relation to clinical trials (maintenance). Fed Reg 1997;62:62922.
8. Ciaravino V, McCullough T, Dayan AD. Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets. Hum Exp Toxicol 2001;20:533-50.
9. Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. Sixth ed. New York: McGraw-Hill; 2001:27.
10. Safety pharmacology studies for human pharmaceuticals S7A (Internet). Geneva: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 1998. Available from: http://www.ich.org/pdfICH/S7step4.pdf.
11. Detection of toxicity to reproduction for medicinal products S5A (Internet). Geneva: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 1998. Available from: http://www.ich.org/pdfICH/s5a.pdf.
12. Genotoxicity S2, specific aspects of regulatory tests S2A, and Standard battery of tests S2B (Internet). Geneva: International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 1998. Available from: http://www.ich.org/ich5s.html#Genotox.
13. Sasaki T, Yoshida T. Experimentelle Erzeugung des Lebercarcinoms durch Futterung mit o-Amidoazotoluol. Virchows Arch Abt a Pathol Anat 1935;295:175-200.
14. , Hadidian Z, Fredrickson TN, Weisburger EK, et al. Tests for chemical carcinogens: report on the activity of derivatives of aromatic amines, nitrosamines, quinolines, nitroalkanes, amides, epoxides, aziridines, and purine antimetabolites. J Natl Cancer Inst 1968;41:985-1036.
15. Hottendorf GH, Pachter IJ. Review and evaluation of the NCI/NTP carcinogenesis bioassays. Toxicol Pathol 1985; 13:141-6.
16. Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. Sixth ed. New York: McGraw-Hill; 2001:293.
17. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992;356:215-21.
18. Harvey M, McArthur MJ, Montgomery CA Jr, et al. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 1993;5:225-9.
19. Dass SB, Bucci TJ, Heflich RH, Casciano DA. Evaluation of transgenic p53+/- mouse for detecting genotoxic liver carcinogens in a short-term bioassay. Cancer Lett 1999; 143:81-5.
20. Sanders JM, Burka LT, Chanas B, Matthews HB. Comparative xenobiotic metabolism between Tg: AC and p53+/- genetically altered mice and their respective wild types. Toxicol Sci 2001;61:54-61.
21. Wagstaff DJ. Dietary exposure to furocoumarins. Regul Toxicol Pharmacol 1991;14:261-72.
22. Chandler R, Diawara MM, Caprioglio H, Chavez KJ, Williams DE. Examination of psoralens-induced photodermatitis in Wistar rats under scanning electron microscopy. J Nat Toxins 1999;8:167-77.
23. Snellman E, Rantanen T. Concentration-dependent phototoxicity in trimethylpsoralen bath psoralen ultraviolet A. Br J Dermatol 2001;144:490-4.
24. Morison WL. Subacute phototoxicity caused by treatment with oral psoralen plus UV-A. Arch Dermatol 1997;133:1609.
25. Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. Sixth ed. New York: McGraw-Hill; 2001:663.
26. Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. Sixth ed. New York: McGraw-Hill; 2001:108.
27. Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. Sixth ed. New York: McGraw-Hill; 2001:73.